Skip to main content
Ian Krop, MD, Oncology, New Haven, CT

IanElliottKropMDPhD

Oncology New Haven, CT

Breast Cancer, Hematologic Oncology

Associate Cancer Director for Clinical Research and Professor of Medicine, Yale Cancer Center

Telehealth Available

Overview of Dr. Krop

Ian Krop, MD, PhD is the Chief Clinical Research Officer and Associate Cancer Center Director for Clinical Research at the Yale Cancer Center. He also serves as the Chief Scientific Officer for the Translational Breast Cancer Research Consortium (TBCRC).

Dr. Krop received his undergraduate, medical and PhD degrees from Johns Hopkins University. He subsequently completed his residency in Internal Medicine at Johns Hopkins Hospital, and fellowship in hematology and medical oncology at Dana-Farber.

Dr. Krop is a translational investigator focused on the development of novel molecularly targeted therapies and immunotherapies for breast cancer, and elucidating the mechanisms of resistance to these treatments. The majority of his effort is concentrated in the area of HER2+ breast cancer. He was a leader in the development of the antibody-drug conjugates trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan

Education & Training

  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicinePhD, 1996
  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineResidency, 1996 - 1999
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1996

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • CT State Medical License
    CT State Medical License 2022 - 2025
  • MA State Medical License
    MA State Medical License 2002 - 2023
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Maximizing ADCs in Breast Cancer: Targets, Sequencing, and More
    Maximizing ADCs in Breast Cancer: Targets, Sequencing, and MoreJune 13th, 2023
  • Will HER3 Targeting Change Breast Cancer Care?
    Will HER3 Targeting Change Breast Cancer Care?July 6th, 2023
  • Palliative Care for Lung Cancer Via Video? Telehealth “Very Viable Option,” Study Shows
    Palliative Care for Lung Cancer Via Video? Telehealth “Very Viable Option,” Study ShowsJune 5th, 2024
  • Join now to see all